Gossamer Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Gossamer Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Gossamer Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Gossamer Bio Inc. is GOSS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Gossamer Bio Inc. has its primary listing on NASDAQ. You can trade Gossamer Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Gossamer Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Gossamer Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Gossamer Bio Inc..